Literature DB >> 29855634

Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.

Alexander T Cohen1, Cihan Ay2, Philippe Hainaut3, Hervé Décousus4, Ulrich Hoffmann5, Sean Gaine6, Michiel Coppens7, Pedro Marques da Silva8, David Jimenez9, Beatrice Amann-Vesti10, Bernd Brüggenjürgen11, Pierre Levy12, Julio Lopez Bastida13, Eric Vicaut14, Petra Laeis15, Eva-Maria Fronk15, Wolfgang Zierhut15, Thomas Malzer15, Peter Bramlage16, Giancarlo Agnelli17.   

Abstract

[This corrects the article DOI: 10.1186/s12959-018-0163-7.].

Entities:  

Year:  2018        PMID: 29855634      PMCID: PMC5977454          DOI: 10.1186/s12959-018-0173-5

Source DB:  PubMed          Journal:  Thromb J        ISSN: 1477-9560


Correction to: Thrombosis Journal (2018) 16:9 DOI 10.1186/s12959-018-0163-7

Following publication of the original article [1], the authors reported that one of the authors’ name was given incorrectly. In this Correction the incorrect and correct author name are shown. The original publication of this article has been corrected. Originally the author name has been published as: David Jimenez Castro The correct author name is: David Jimenez
  1 in total

1.  Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.

Authors:  Alexander T Cohen; Cihan Ay; Philippe Hainaut; Hervé Décousus; Ulrich Hoffmann; Sean Gaine; Michiel Coppens; Pedro Marques da Silva; David Jimenez Castro; Beatrice Amann-Vesti; Bernd Brüggenjürgen; Pierre Levy; Julio Lopez Bastida; Eric Vicaut; Petra Laeis; Eva-Maria Fronk; Wolfgang Zierhut; Thomas Malzer; Peter Bramlage; Giancarlo Agnelli
Journal:  Thromb J       Date:  2018-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.